Blennow K, de Leon MJ, Zetterberg H: Alzheimer's disease. The Lancet. 368 (9533): 387-403. 10.1016/S0140-6736(06)69113-7.
Golde TE, Eckman CB, Younkin SG: Biochemical detection of Abeta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochim Biophys Acta. 2000, 1502 (1): 172-187.
Article
PubMed
CAS
Google Scholar
Younkin SG: The role of A beta 42 in Alzheimer's disease. J Physiol Paris. 1998, 92 (3-4): 289-292. 10.1016/S0928-4257(98)80035-1.
Article
PubMed
CAS
Google Scholar
Selkoe DJ: Clearing the brain's amyloid cobwebs. Neuron. 2001, 32 (2): 177-180. 10.1016/S0896-6273(01)00475-5.
Article
PubMed
CAS
Google Scholar
Selkoe DJ, Podlisny MB: Deciphering the genetic basis of alzheimer's disease. Annual Review of Genomics and Human Genetics. 2002, 3 (1): 67-99. 10.1146/annurev.genom.3.022502.103022.
Article
PubMed
CAS
Google Scholar
Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S: Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med. 1996, 2 (8): 864-870. 10.1038/nm0896-864.
Article
PubMed
CAS
Google Scholar
Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S: Increased amyloid-[beta]42(43) in brains of mice expressing mutant presenilin 1. Nature. 1996, 383 (6602): 710-713. 10.1038/383710a0.
Article
PubMed
CAS
Google Scholar
Games D, Adams D, Alessandrini R, Barbour R, Borthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J: Alzheimer-type neuropathology in transgenic mice overexpressing V717F [beta]-amyloid precursor protein. Nature. 1995, 373 (6514): 523-527. 10.1038/373523a0.
Article
PubMed
CAS
Google Scholar
Iijima K, Liu HP, Chiang AS, Hearn SA, Konsolaki M, Zhong Y: Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. Proc Natl Acad Sci U S A. 2004, 101 (17): 6623-6628. 10.1073/pnas.0400895101.
Article
PubMed
CAS
PubMed Central
Google Scholar
Greeve I, Kretzschmar D, Tschape JA, Beyn A, Brellinger C, Schweizer M, Nitsch RM, Reifegerste R: Age-dependent neurodegeneration and Alzheimer-amyloid plaque formation in transgenic Drosophila. J Neurosci. 2004, 24 (16): 3899-3906. 10.1523/JNEUROSCI.0283-04.2004.
Article
PubMed
CAS
Google Scholar
Lleo A, Greenberg SM, Growdon JH: Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006, 57: 513-533. 10.1146/annurev.med.57.121304.131442.
Article
PubMed
CAS
Google Scholar
Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev. 2006, CD005593.
Google Scholar
McShane R, Areosa Sastre A, Minakaran N: Memantine for dementia. Cochrane Database Syst Rev. 2006, CD003154.
Google Scholar
Seltzer B: Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment. J Int Med Res. 2006, 34 (4): 339-347.
Article
PubMed
CAS
Google Scholar
Smith M, Wells J, Borrie M: Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord. 2006, 20 (3): 133-137. 10.1097/00002093-200607000-00002.
Article
PubMed
CAS
Google Scholar
Etminan M, Gill S, Samii A: Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies. BMJ. 2003, 327 (7407): 128-10.1136/bmj.327.7407.128.
Article
PubMed
CAS
PubMed Central
Google Scholar
McGeer PL, McGeer EG: Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci. 2004, 1035: 104-116. 10.1196/annals.1332.007.
Article
PubMed
CAS
Google Scholar
Townsend KP, Pratico D: Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. FASEB J. 2005, 19 (12): 1592-1601. 10.1096/fj.04-3620rev.
Article
PubMed
CAS
Google Scholar
Rogers J, Kirby LC, Hempelman SR, Berry DL, McGeer PL, Kaszniak AW, Zalinski J, Cofield M, Mansukhani L, Willson P, Kogan F: Clinical trial of indomethacin in Alzheimer's disease. Neurology. 1993, 43 (8): 1609.
Article
PubMed
CAS
Google Scholar
Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N: A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology. 1999, 53 (1): 197-201.
Article
PubMed
CAS
Google Scholar
Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ: Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA. 2003, 289 (21): 2819-2826. 10.1001/jama.289.21.2819.
Article
PubMed
CAS
Google Scholar
van Gool WA, Aisen PS, Eikelenboom P: Anti-inflammatory therapy in Alzheimer's disease: is hope still alive?. J Neurol. 2003, 250 (7): 788-792. 10.1007/s00415-003-1146-5.
Article
PubMed
CAS
Google Scholar
McGeer PL, McGeer EG: NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies. Neurobiol Aging. 2006
Google Scholar
Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA, Cole GM: Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease. J Neurosci. 2000, 20 (15): 5709-5714.
PubMed
CAS
Google Scholar
Gasparini L, Ongini E, Wilcock D, Morgan D: Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease. Brain Research Reviews. 2005, 48 (2): 400-408. 10.1016/j.brainresrev.2004.12.029.
Article
PubMed
CAS
Google Scholar
Prosperi C, Scali C, Barba M, Bellucci A, Giovannini MG, Pepeu G, Casamenti F: Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat. Int J Immunopathol Pharmacol. 2004, 17 (3): 317-330.
PubMed
CAS
Google Scholar
Jantzen PT, Connor KE, DiCarlo G, Wenk GL, Wallace JL, Rojiani AM, Coppola D, Morgan D, Gordon MN: Microglial Activation and beta -Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice. J Neurosci. 2002, 22 (6): 2246-2254.
PubMed
CAS
Google Scholar
Sung S, Yang H, Uryu K, Lee EB, Zhao L, Shineman D, Trojanowski JQ, Lee VMY, Pratico D: Modulation of Nuclear Factor-{kappa}B Activity by Indomethacin Influences A{beta} Levels but Not A{beta} Precursor Protein Metabolism in a Model of Alzheimer's Disease. Am J Pathol. 2004, 165 (6): 2197-2206.
Article
PubMed
CAS
PubMed Central
Google Scholar
Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T, Kang DE, Marquez-Sterling N, Golde TE, Koo EH: A subset of NSAIDs lower amyloidogenic A[beta]42 independently of cyclooxygenase activity. Nature. 2001, 414 (6860): 212-216. 10.1038/35102591.
Article
PubMed
CAS
Google Scholar
Eriksen JL, Sagi SA, Smith TE, Weggen S, Das P, McLendon DC, Ozols VV, Jessing KW, Zavitz KH, Koo EH, Golde TE: NSAIDs and enantiomers of flurbiprofen target {gamma}-secretase and lower A{beta}42 in vivo. J Clin Invest. 2003, 112 (3): 440-449. 10.1172/JCI200318162.
Article
PubMed
CAS
PubMed Central
Google Scholar
Kukar T, Murphy MP, Eriksen JL, Sagi SA, Weggen S, Smith TE, Ladd T, Khan MA, Kache R, Beard J, Dodson M, Merit S, Ozols VV, Anastasiadis PZ, Das P, Fauq A, Koo EH, Golde TE: Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production. Nat Med. 2005, 11 (5): 545-550. 10.1038/nm1235.
Article
PubMed
CAS
Google Scholar
Sagi SA, Weggen S, Eriksen J, Golde TE, Koo EH: The Non-cyclooxygenase Targets of Non-steroidal Anti-inflammatory Drugs, Lipoxygenases, Peroxisome Proliferator-activated Receptor, Inhibitor of {kappa}B Kinase, and NF{kappa}B, Do Not Reduce Amyloid {beta}42 Production. J Biol Chem. 2003, 278 (34): 31825-31830. 10.1074/jbc.M303588200.
Article
PubMed
CAS
Google Scholar
Weggen S, Eriksen JL, Sagi SA, Pietrzik CU, Ozols V, Fauq A, Golde TE, Koo EH: Evidence That Nonsteroidal Anti-inflammatory Drugs Decrease Amyloid {beta}42 Production by Direct Modulation of {gamma}-Secretase Activity. J Biol Chem. 2003, 278 (34): 31831-31837. 10.1074/jbc.M303592200.
Article
PubMed
CAS
Google Scholar
Takahashi Y, Hayashi I, Tominari Y, Rikimaru K, Morohashi Y, Kan T, Natsugari H, Fukuyama T, Tomita T, Iwatsubo T: Sulindac Sulfide Is a Noncompetitive gamma -Secretase Inhibitor That Preferentially Reduces Abeta 42 Generation. J Biol Chem. 2003, 278 (20): 18664-18670. 10.1074/jbc.M301619200.
Article
PubMed
CAS
Google Scholar
Beher D, Clarke EE, Wrigley JDJ, Martin ACL, Nadin A, Churcher I, Shearman MS: Selected Non-steroidal Anti-inflammatory Drugs and Their Derivatives Target {gamma}-Secretase at a Novel Site: EVIDENCE FOR AN ALLOSTERIC MECHANISM. J Biol Chem. 2004, 279 (42): 43419-43426. 10.1074/jbc.M404937200.
Article
PubMed
CAS
Google Scholar
Geisslinger G, Lotsch J, Menzel S, Kobal G, Brune K: Stereoselective disposition of flurbiprofen in healthy subjects following administration of the single enantiomers. Br J Clin Pharmacol. 1994, 37 (4): 392-394.
Article
PubMed
CAS
PubMed Central
Google Scholar
Geisslinger G, Muth-Selbach U, Coste O, Vetter G, Schrodter A, Schaible HG, Brune K, Tegeder I: Inhibition of Noxious Stimulus-Induced Spinal Prostaglandin E2 Release by Flurbiprofen Enantiomers. A Microdialysis Study. Journal of Neurochemistry. 2000, 74 (5): 2094-2100. 10.1046/j.1471-4159.2000.0742094.x.
Article
PubMed
CAS
Google Scholar
Morihara T, Chu T, Ubeda O, Beech W, Cole GM: Selective inhibition of Abeta42 production by NSAID R-enantiomers. Journal of Neurochemistry. 2002, 83 (4): 1009-1012. 10.1046/j.1471-4159.2002.01195.x.
Article
PubMed
CAS
Google Scholar
Black S: Efficacy and safety of MPC-7869 (R-flurbiprofen), a selective Abeta42 lowering agent in mild Alzheimer's disease: results of a 12-month phase 2 trial and 1-year follow on study. Neurology. 2006, 66(Suppl2) (A347).
McDonald RJ, White NM: Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. Behav Neural Biol. 1994, 61 (3): 260-270. 10.1016/S0163-1047(05)80009-3.
Article
PubMed
CAS
Google Scholar
Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF: Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol. 2003, 184 (1): 510-520. 10.1016/S0014-4886(03)00399-6.
Article
PubMed
Google Scholar
Quinn JF, Bussiere JR, Hammond RS, Montine TJ, Henson E, Jones RE, Stackman RW: Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol Aging. 2007, 28 (2): 213-225. 10.1016/j.neurobiolaging.2005.12.014.
Article
PubMed
CAS
Google Scholar
Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH: The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci. 2002, 22 (5): 1858-1867.
PubMed
CAS
Google Scholar
Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH: A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006, 440 (7082): 352-357. 10.1038/nature04533.
Article
PubMed
CAS
Google Scholar
Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D: A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature. 2000, 408 (6815): 979-982. 10.1038/35050110.
Article
PubMed
CAS
Google Scholar
Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW: A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature. 2000, 408 (6815): 982-985. 10.1038/35050116.
Article
PubMed
CAS
Google Scholar
Arendash GW, Gordon MN, Diamond DM, Austin LA, Hatcher JM, Jantzen P, DiCarlo G, Wilcock D, Morgan D: Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol. 2001, 20 (11): 737-744. 10.1089/10445490152717604.
Article
PubMed
CAS
Google Scholar
Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM: Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci. 2002, 5 (5): 452-457.
PubMed
CAS
Google Scholar
Kotilinek LA, Bacskai B, Westerman M, Kawarabayashi T, Younkin L, Hyman BT, Younkin S, Ashe KH: Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci. 2002, 22 (15): 6331-6335.
PubMed
CAS
Google Scholar
Lazarov O, Robinson J, Tang YP, Hairston IS, Korade-Mirnics Z, Lee VM, Hersh LB, Sapolsky RM, Mirnics K, Sisodia SS: Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell. 2005, 120 (5): 701-713. 10.1016/j.cell.2005.01.015.
Article
PubMed
CAS
Google Scholar
Costa DA, Cracchiolo JR, Bachstetter AD, Hughes TF, Bales KR, Paul SM, Mervis RF, Arendash GW, Potter H: Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging. 2006
Google Scholar
Leipold DD, Kantoci D, Murray ED, Quiggle DD, Wechter WJ: Bioinversion of R-flurbiprofen to S-flurbiprofen at various dose levels in rat, mouse, and monkey. Chirality. 2004, 16 (6): 379-387. 10.1002/chir.20053.
Article
PubMed
CAS
Google Scholar
Wallace JL, Muscara MN, de Nucci G, Zamuner S, Cirino G, del Soldato P, Ongini E: Gastric Tolerability and Prolonged Prostaglandin Inhibition in the Brain with a Nitric Oxide-Releasing Flurbiprofen Derivative, NCX-2216 [3-[4-(2-Fluoro-{alpha}-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoic acid 4-nitrooxy butyl ester]. J Pharmacol Exp Ther. 2004, 309 (2): 626-633. 10.1124/jpet.103.063453.
Article
PubMed
CAS
Google Scholar
Thomas T, Nadackal TG, Thomas K: Aspirin and non-steroidal anti-inflammatory drugs inhibit amyloid-beta aggregation. Neuroreport. 2001, 12 (15): 3263-3267. 10.1097/00001756-200110290-00024.
Article
PubMed
CAS
Google Scholar
Hirohata M, Ono K, Naiki H, Yamada M: Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's [beta]-amyloid fibrils in vitro. Neuropharmacology. 2005, 49 (7): 1088-1099. 10.1016/j.neuropharm.2005.07.004.
Article
PubMed
CAS
Google Scholar
Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E, Borghgraef P, Evert BO, Dumitrescu-Ozimek L, Thal DR, Landreth G, Walter J, Klockgether T, van Leuven F, Heneka MT: Nonsteroidal anti-inflammatory drugs repress {beta}-secretase gene promoter activity by the activation of PPAR{gamma}. PNAS. 2006, 103 (2): 443-448. 10.1073/pnas.0503839103.
Article
PubMed
CAS
PubMed Central
Google Scholar
Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice. Science. 1996, 274 (5284): 99-103. 10.1126/science.274.5284.99.
Article
PubMed
CAS
Google Scholar
McGowan E, Pickford F, Kim J, Onstead L, Eriksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Golde T: Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron. 2005, 47 (2): 191-199. 10.1016/j.neuron.2005.06.030.
Article
PubMed
CAS
PubMed Central
Google Scholar
Garcia MF, Gordon MN, Hutton M, Lewis J, McGowan E, Dickey CA, Morgan D, Arendash GW: The retinal degeneration (rd) gene seriously impairs spatial cognitive performance in normal and Alzheimer's transgenic mice. Neuroreport. 2004, 15 (1): 73-77. 10.1097/00001756-200401190-00015.
Article
PubMed
CAS
Google Scholar
Gallagher M, Burwell R, Burchinal M: Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav Neurosci. 1993, 107 (4): 618-626. 10.1037/0735-7044.107.4.618.
Article
PubMed
CAS
Google Scholar
Levites Y, Das P, Price RW, Rochette MJ, Kostura LA, McGowan EM, Murphy MP, Golde TE: Anti-A{beta}42- and anti-A{beta}40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J Clin Invest. 2006, 116 (1): 193-201. 10.1172/JCI25410.
Article
PubMed
CAS
PubMed Central
Google Scholar
Das P, Smithson LA, Price RW, Holloway VM, Levites Y, Chakrabarty P, Golde TE: Interleukin-1 receptor 1 knockout has no effect on amyloid deposition in Tg2576 mice and does not alter efficacy following Abeta immunotherapy. J Neuroinflammation. 2006, 3: 17-10.1186/1742-2094-3-17.
Article
PubMed
PubMed Central
Google Scholar